sur SYNLAB
SYNLAB's Strategic Expansion in Italy Enhances Diagnostic Precision
SYNLAB, a leader in European medical diagnostic services, has announced a significant investment in Italy. The company is pioneering the installation of a photon-counting CT scanner at its Naples research center. This move exemplifies SYNLAB's commitment to providing cutting-edge diagnostics and enhancing patient experience.
Photon-counting CT represents a breakthrough in radiology, improving imaging with ultra-high resolution and minimizing radiation exposure. This technology, integrated with advanced AI, aims to enhance image quality, speed up reporting, and provide more accurate diagnostics. It is crucial for complex cases like coronary disease and tumor staging, offering clinicians detailed insights for timely decisions.
SYNLAB has invested over €9 million in Italy's imaging diagnostics in recent years, further solidifying its position as a key diagnostic partner in the region.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de SYNLAB